BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2011
View Archived Issues
123I-DRM-106 to be developed for SPECT imaging of amyloid plaques
Read More
Micro-NMR operated by smart phone for accurate diagnosis of malignant tumors
Read More
Pioglitazone reduces the formation of renal stones in rats
Read More
Karo Bio and Zydus Cadila extend glucocorticoid research collaboration
Read More
Benefits reported for fesoterodine in elderly patients with overactive bladder
Read More
XenoPort reports data from phase IIb arbaclofen placarbil trial in GERD
Read More
Phase IIa clinical trial of NasVax's anti-CD3 MAb immunotherapy meets all endpoints
Read More
NKTR-181 displays reduced CNS side effect potential compared to oxycodone
Read More
Six-month data show improvements in childhood hypophosphatasia with ENB-0040
Read More
Novel tubulisine derivatives for cancer prepared at KemoTech
Read More
Sanofi-aventis patents new series of tryptase inhibitors
Read More
United Therapeutics' FREEDOM-C(2) registration trial for UT-15C fully enrolled
Read More
FDA assigns PDUFA date to Shire's resubmission of Firazyr for treatment of HAE
Read More
Ipilimumab improves overall survival in phase III trial in metastatic melanoma
Read More
New phosphatidylcholine transfer protein inhibitors patented by Brigham & Women's Hospital
Read More
Intellikine scientists synthesize novel PI3K inhibitors
Read More
Alzheimer's Drug Discovery Foundation supports ADispell's neuroprotective drug research
Read More
Seattle Genetics forms antibody-drug conjugate collaboration with Abbott
Read More
Cellerant Therapeutics begins phase I/II CLT-008 trial for neutropenia in leukemia
Read More
Johns Hopkins patents novel inhibitors of LSD1 for cancer
Read More
Quest Diagnostics signs agreement to acquire Celera
Read More
Provectus and FDA hold second end-of-phase II meeting on PV-10 for melanoma
Read More
Tesaro acquires rights to Amgen's anaplastic lymphoma kinase program
Read More
Aradigm completes enrollment in phase IIb inhaled ciprofloxacin trial
Read More
Asahi Kasei obtains exclusive rights to Xiaflex for two indications in Japan
Read More
FDA extends review of Novartis's NDA for QAB-149, a once-daily bronchodilator for COPD
Read More